PROTECT-C offers Direct to Participant saliva based genetic testing for cancer susceptibility genes BRCA1, BRCA2, RAD51 clinical trials

A population-based digital study offering people testing for cancer genes, to identify people at increased risk of cancer so they can take steps to prevent it or detect it early

This study offers a genetic test for cancer risk to people in the UK. It uses a saliva sample to check for genes linked to breast, ovarian, bowel, and womb cancers. The aim is to find people at higher risk so they can take steps to prevent cancer or detect it early.